UPDATE: MLV & Co Initiates Coverage On Ultragenyx Pharmaceutical On Positive Outlook

By: via Benzinga
In a report published Tuesday, MLV & Co analyst Arlinda Lee initiated coverage on Ultragenyx Pharmaceutical, Inc. (NASDAQ: RARE) with a ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.